Literature DB >> 10579124

Postoperative recurrence of Crohn's disease: pathophysiology and prevention.

G D'Haens1, P Rutgeerts.   

Abstract

Postoperative recurrence of Crohn's disease is often inevitable. Certain risk factors such as smoking, young age, and a perforating disease behavior have been identified. Patients running an enhanced risk should be treated with mesalamine or, with higher success rates, with azathioprine. An endoscopic evaluation of the neoterminal ileum 6 to 12 months after surgery provides relevant information predicting the further clinical course and can be used as a guide to adjust medical therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10579124     DOI: 10.1097/00054725-199911000-00010

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

1.  Phenotype at diagnosis predicts recurrence rates in Crohn's disease.

Authors:  F L Wolters; M G Russel; J Sijbrandij; T Ambergen; S Odes; L Riis; E Langholz; P Politi; A Qasim; I Koutroubakis; E Tsianos; S Vermeire; J Freitas; G van Zeijl; O Hoie; T Bernklev; M Beltrami; D Rodriguez; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

2.  Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileum.

Authors:  Narendra Vadlamudi; Naim Alkhouri; Lori Mahajan; Rocio Lopez; Bo Shen
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

3.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

Authors:  C Prantera; M L Scribano; G Falasco; A Andreoli; C Luzi
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

4.  Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty.

Authors:  David G Binion; Kenneth R Theriot; Sushrut Shidham; Sarah Lundeen; Ossama Hatoum; Hyun J Lim; Mary F Otterson
Journal:  J Gastrointest Surg       Date:  2007-12       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.